International Isotopes gets go-ahead
Radioisotope manufacturer International Isotopes of Denton, TX, reported last month that the Texas Department of Public Health's Bureau of Radiation Control has approved a license amendment for the production of small quantities of thallium-201, a
Radioisotope manufacturer International Isotopes of Denton, TX, reported last month that the Texas Department of Public Health's Bureau of Radiation Control has approved a license amendment for the production of small quantities of thallium-201, a radioisotope used for the diagnosis of heart disease and cardiac function. The isotope will be manufactured using International Isotopes' linear accelerator, as well as its cyclotron.
The approval allows the firm to begin preliminary shipments of thallium and other radiochemicals to pharmaceutical companies, a crucial step in establishing itself as a reliable provider of raw pharmaceutical material, according to Carl Seidel, president and CEO. International Isotopes will begin shipping thallium in early March, but declined to name particular customers.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
